Compounders Research Compare

Gossamer Bio, Inc.(GOSS)

Biotechnology · San Diego, CA

$10.58-0.07 (-0.66%)

Delayed quote: Oct 6, 2026, 2:23 PM EDT

About Gossamer Bio, Inc.

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. The company develops GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.

San Diego, CA

162 employees

www.gossamerbio.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Faheem Hasnain

View full financials

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T18:26:47.305Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:26:47.305Z.

Quote observation: 2026-10-06T18:23:56.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -55.66
Quote price: 10.58

FMP input reference: b98ba4015092d5f9d3a8f7230bb6a5b98cf1bb4c669b9b66f04bb37649ead8fd

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

GOSS Earnings Yield Metrics

EARNINGS YIELD

N/A

GOSS Competitors' Earnings Yield

Gossamer Bio, Inc.

Current

Market Cap

$64.65M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

InterCure Ltd.

Market Cap

$63.64M

Earnings Yield

N/A

TTM Avg

7.80%

3Y Avg

4.49%

5Y Avg

5.28%

XBiotech Inc.

Market Cap

$65.85M

Earnings Yield

N/A

TTM Avg

114.91%

3Y Avg

114.91%

5Y Avg

114.91%

Heron Therapeutics, Inc.

Market Cap

$63.45M

Earnings Yield

N/A

TTM Avg

34.60%

3Y Avg

34.60%

5Y Avg

34.60%

Alps Group Inc

Market Cap

$63.25M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Cingulate Inc.

Market Cap

$66.40M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Pliant Therapeutics, Inc.

Market Cap

$62.85M

Earnings Yield

N/A

TTM Avg

2.54%

3Y Avg

2.54%

5Y Avg

2.54%

RenovoRx, Inc.

Market Cap

$62.85M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Fractyl Health, Inc.

Market Cap

$61.67M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

iBio, Inc.

Market Cap

$67.84M

Earnings Yield

N/A

TTM Avg

1.65%

3Y Avg

1.65%

5Y Avg

1.65%

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Gossamer Bio, Inc. (GOSS)	$64.65M	N/A	N/A	N/A	N/A
InterCure Ltd. (INCR)vs ›	$63.64M	N/A	7.80%	4.49%	5.28%
XBiotech Inc. (XBIT)vs ›	$65.85M	N/A	114.91%	114.91%	114.91%
Heron Therapeutics, Inc. (HRTX)vs ›	$63.45M	N/A	34.60%	34.60%	34.60%
Alps Group Inc (ALPS)vs ›	$63.25M	N/A	N/A	N/A	N/A
Cingulate Inc. (CING)vs ›	$66.40M	N/A	N/A	N/A	N/A
Pliant Therapeutics, Inc. (PLRX)vs ›	$62.85M	N/A	2.54%	2.54%	2.54%
RenovoRx, Inc. (RNXT)vs ›	$62.85M	N/A	N/A	N/A	N/A
Fractyl Health, Inc. (GUTS)vs ›	$61.67M	N/A	N/A	N/A	N/A
iBio, Inc. (IBIO)vs ›	$67.84M	N/A	1.65%	1.65%	1.65%

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Yield Dividend Yield All Metrics